Clinical impact of genetic alterations of CTNNB1 in patients with grade 3 endometrial endometrioid carcinoma

To identify prognostic factors in patients with grade 3 (high‐grade) endometrial endometrioid carcinoma, we evaluated the spectrum of genomic alterations and examined whether previously reported molecular subtypes of endometrial carcinoma were adapted to clinical outcome prediction. Seventy‐five Jap...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi Kato, Mayumi, Asami, Yuka, Takayanagi, Daisuke, Matsuda, Maiko, Shimada, Yoko, Hiranuma, Kengo, Kuno, Ikumi, Komatsu, Masaaki, Hamamoto, Ryuji, Matsumoto, Koji, Ishikawa, Mitsuya, Kohno, Takashi, Kato, Tomoyasu, Shiraishi, Kouya, Yoshida, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128156/
https://www.ncbi.nlm.nih.gov/pubmed/35278272
http://dx.doi.org/10.1111/cas.15328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128156/
https://www.ncbi.nlm.nih.gov/pubmed/35278272
http://dx.doi.org/10.1111/cas.15328

Ejemplares similares